Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.51 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | FOS | P01100 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | JUN | P05412 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.47 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6553382 | 0.90 | SMN1; SMN2 (0.50) | MTNR1AMTNR1BLMNASMN1; SMN2ALOX5 | |
| SCHEMBL6553375 | 0.90 | SMN1; SMN2 (0.50) | MTNR1AMTNR1BLMNASMN1; SMN2ALOX5 | |
| SCHEMBL13350377 | 0.81 | KMT2A (0.52) | LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL8379773 | 0.81 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL13883457 | 0.81 | MTNR1A (0.60) | MTNR1AMTNR1BLMNAALOX5OR51E2 | |
| SCHEMBL6553795 | 0.80 | KMT2A (0.51) | LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL7156994 | 0.80 | MAPT (0.52) | LMNASMN1; SMN2KMT2A | |
| SCHEMBL6555978 | 0.80 | MAPT (0.52) | LMNASMN1; SMN2KMT2A | |
| SCHEMBL6554738 | 0.80 | KMT2A (0.51) | LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL6556821 | 0.80 | ALDH1A1 (0.48) | LMNASMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1135368-B1 | ALPHA-SULFIN- AND ALPHA-SULFON-AMINO ACID AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-02-25 | — | — | EP | disclosed |
| US-6538016-B2 | For controlling and preventing an infestation of crop plants by phytopathogenic microorganisms, preferably fungi | SYNGENTA PARTICIPATIONS AG (CH) | 2003-03-25 | — | — | US | disclosed |
| US-6482859-B1 | Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives | SYNGENTA CROP PROTECTION, INC. | 2002-11-19 | — | — | US | disclosed |
| US-20020082452-A1 | alpha-sulfin-and alpha-sulfonamino acid amides | SYNGENTA PARTICIPATIONS AG (CH) | 2002-06-27 | — | — | US | disclosed |
| EP-1003719-B1 | MICROBICIDAL N-SULFONYLGLYCIN ALKYNYLOXYPHENEMETHYL AMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2002-06-05 | — | — | EP | disclosed |
| EP-1135368-A2 | ALPHA-SULFIN- AND ALPHA-SULFON-AMINO ACID AMIDES | Syngenta Participations AG (CH) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000032568-A2 | $G(A)-SULFIN- AND $G(A)-SULFONAMINO ACID AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2000-06-08 | — | — | WO | disclosed |
| EP-1003719-A2 | MICROBICIDAL N-SULFONYLGLYCIN ALKYNYLOXYPHENEMETHYL AMIDE DERIVATIVES | Novartis AG (CH) | 2000-05-31 | — | — | EP | disclosed |
| WO-1999007674-A2 | MICROBICIDAL N-SULFONYLGLYCIN ALKYNYLOXYPHENEMETHYL AMIDE DERIVATIVES | NOVARTIS AG (CH) | 1999-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082452-A1 | alpha-sulfin-and alpha-sulfonamino acid amides | SULT1A1, CBR1, SULT2A1 | MTNR1A 139/4885MTNR1B 292/4885LMNA 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.